Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature M. GhilliM. D. MarinielloM. Roncella Review 03 April 2018 Pages: 445 - 454
Effects of physical exercise after treatment of early breast cancer: systematic review and meta-analysis Frederico Soares FalcettaHenrique de Araújo Vianna TräselDaniela Dornelles Rosa Review 13 April 2018 Pages: 455 - 476
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis Pranabananda DuttaMarianna SarkissyanJaydutt V. Vadgama Preclinical study Open access 28 March 2018 Pages: 477 - 486
Association of reproductive history with breast tissue characteristics and receptor status in the normal breast Marike GabrielsonFlaminia ChiesaPer Hall Preclinical study Open access 30 March 2018 Pages: 487 - 497
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer Karineh PetrossianDuc NguyenShiuan Chen Preclinical study 05 April 2018 Pages: 499 - 506
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness Hidetaka ShimaKumiko KidaItaru Endo Preclinical study 24 April 2018 Pages: 507 - 516
Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients Marc D. SchwartzBeth N. PeshkinKatia Khoury Clinical trial 02 April 2018 Pages: 517 - 524
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis Sasagu KurozumiChitra JosephEmad A. Rakha Clinical trial 09 April 2018 Pages: 525 - 533
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2 Sunil VermaJoyce O’ShaughnessyWolfgang Janni Clinical trial Open access 13 April 2018 Pages: 535 - 545
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation Joyce O’ShaughnessyAngela DeMicheleHope S. Rugo Clinical trial 19 April 2018 Pages: 547 - 557
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy Waqar HaqueVivek VermaBin S. Teh Clinical trial 24 April 2018 Pages: 559 - 567
Impact of port site scar on perception of patients with breast cancer: patient-reported outcomes Amy VociDavid LeeMaggie DiNome Clinical trial 24 April 2018 Pages: 569 - 572
FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment Anna WilkinsRitika ChauhanNavita Somaiah Clinical trial Open access 26 April 2018 Pages: 573 - 581
Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan Kun-Ming RauFu Ou-YangMing-Feng Hou Epidemiology Open access 05 April 2018 Pages: 583 - 591
Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient–provider interactions Devon K. CheckNeetu ChawlaLawrence H. Kushi Epidemiology 05 April 2018 Pages: 593 - 603
Pre-diagnostic changes in body mass index and mortality among breast cancer patients Signe Benzon LarsenMaia TorstenssonPernille Envold Bidstrup Epidemiology 10 April 2018 Pages: 605 - 612
An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort Mark A. GuinterAlexander C. McLainSusan E. Steck Epidemiology 12 April 2018 Pages: 613 - 622
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system Candyce H. KroenkeDawn L. HershmanLawrence H. Kushi Epidemiology 18 April 2018 Pages: 623 - 631
Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews Julia HackettRachael ThorneloeSamuel G. Smith Epidemiology Open access 24 April 2018 Pages: 633 - 640
Bilateral mastectomies: can a co-surgeon technique offer improvements over the single-surgeon method? Melissa Anne MalloryConstantine TarabanisMehra Golshan Epidemiology 23 April 2018 Pages: 641 - 646
The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer Victoria SopikSteven A. Narod Epidemiology Open access 24 April 2018 Pages: 647 - 656
Physician peer group characteristics and timeliness of breast cancer surgery Jacqueline BachandPamela R. SoulosCary P. Gross Epidemiology 24 April 2018 Pages: 657 - 665
Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies Sohyun KimYeonsook KoJung-eun Lim Epidemiology 30 April 2018 Pages: 667 - 675
A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer Anuhya KommalapatiSri Harsha TellaPavan Kumar Tandra Brief Report 02 May 2018 Pages: 677 - 685